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Dyspneic patients are commonly encountered by Emergency MedicalService (EMS).Frequent causes include ChronicObstructive
Pulmonary Disease (COPD) and Congestive Heart Failure (CHF). Measurement of peak expiratory ﬂow rate (PEFR) has been
proposed to help diﬀerentiate COPD from CHF. This prospective, cohort, pilot study was conducted to determine if PEFR in
patients with an exacerbation of COPD were signiﬁcantly diﬀerent than CHF. Included were patients presenting with dyspnea
plus a history of COPD and/or CHF. A PEFR was measured, values were compared to predicted average, and a percentage was
calculated. Twenty-one patients were enrolled. Six had a diagnosis of COPD, 12 CHF; 3 had other diagnoses. Mean percentage of
predicted PEFR with COPD was 26.36%, CHF 48.9% (P = 0.04). Patients presenting with acute COPD had signiﬁcantly lower
percentage of predicted PEFR than those with CHF. These results suggest that PEFR may be useful in diﬀerentiating COPD from
CHF. This study should be expanded to the prehospital setting with a larger number of subjects.
1.Introduction
Dyspnea, a common cause of Emergency Medical Service
(EMS) calls, can result from problems involving many organ
systems. Some of the more frequently encountered scenarios
are Chronic Obstructive Pulmonary Disease (COPD) and/or
Congestive Heart Failure (CHF) which have diﬀerent treat-
ment regimens [1]. It is estimated that approximately 14
million Americans have COPD and ﬁve million carry the
diagnosis of CHF [2]. These patients require rapid and accu-
rateevaluationinordertoprovidethepropercourseoftreat-
ment. Studies have shown that physical examination alone is
notalwayssuﬃcienttodeterminetheunderlyingcauseofthe
patient’s dyspnea. Both diagnoses may present with similar
physical ﬁndings such as wheezing, rales, and jugular venous
distension [3]. In the Emergency Department (ED), physi-
cians have access to several diagnostic aids to assist in deter-
mining the cause of the dyspnea that are not available in the
EMS setting. Peak expiratory ﬂow meters are small, inexpen-
sive, and accessible devices used to measure the peak expi-
ratory ﬂow rate (PEFR) after maximal inspiration. They are
commonly prescribed for asthma patients but have shown
promise in assessing COPD [4, 5]. Peak expiratory ﬂow is
not part of the standard protocol for gauging CHF patients,
although several studies have suggested that PEFR may be
useful in helping to diﬀerentiate cardiac from pulmonary
causesofdyspnea[3,5].Thepurposeofthisstudyistodeter-
mine if peak expiratory ﬂow meters are eﬀective in assisting
EMS personnel in diﬀerentiating the respiratory and car-
diovascular etiologies of dyspnea, and if so, to what extent.
We hypothesize that the measured peak expiratory ﬂow
value calculated as a percentage of an established predicted
value will be signiﬁcantly lower in patients whose respiratory
symptoms represent an exacerbation of COPD as opposed to
CHF. As an initial step in testing this hypothesis, the authors
chose to perform a data collection in the ED to determine if
use of the PEFR may be useful in the prehospital setting.
2.MaterialsandMethods
This prospective, cohort, pilot study was conducted in the
ED over a two-month period. A convenience sample of
patients were enrolled based on their chief complaint and
suspected history as recorded in triage or by EMS. Only2 Emergency Medicine International
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Figure 1: % Predicted peak ﬂow measurement: COPD versus CHF.
those patients who presented with a history of COPD or
CHF were included in the study. Patients were excluded if
they were unable to cooperate with peak ﬂow testing, or if
any interventions, other than oxygen administration, were
initiated by EMS, nursing or medical staﬀ prior to obtaining
the PEFR measurements. Once the patient was placed in a
room, investigators obtained informed consent and a brief
history. The patient was then given instructions on how to
perform the peak expiratory ﬂow test, and three attempts
were made. The peak ﬂow measurements were taken by one
of the authors (J. E. Gough) or one of the study assistants
trained in measuring PEFR. The treating physicians were
blinded to the results of the PEFR testing. The highest
peak expiratory value was recorded and considered the
p a t i e n t ’ sb e s te ﬀort. This value was then compared to a
standard predicted value based on the patient’s height and
age. A percentage of predicted value was calculated and
used for the purpose of statistical analysis [6]. The patient’s
history, previous diagnoses, and discharge diagnosis were
conﬁrmed using medical records at a later date. The means
of the percentages of predicted values were calculated and
compared among the COPD and CHF subgroups. Statistical
signiﬁcance was determined using an unpaired t-test with
P = 0.05 indicating a signiﬁcant diﬀerence.
3. Results
Twenty-one total patients were enrolled in the study. The
mean age for the patients enrolled was 61 ± 12.27 years.
Six had a ﬁnal diagnosis of COPD, 12 had a ﬁnal diagnosis
o fC H F ,a n d3h a dad i ﬀerent diagnosis. The mean % of
predicted PEFR for patients with a history of COPD was
26.4 ± 14.3. For patients with CHF, it was 48.9 ± 22.6.
The P value was calculated as 0.04 (Figure 1). Only those
with diagnoses of CHF or COPD were included in the data
analysis (Table 1).
There were 6 patients enrolled which had a known
history of COPD. These patients had a mean PEFR of 35.8%;
all received a ﬁnal diagnosis of COPD. There were twelve
Table 1: Patients enrolled in study.
Age Predicted
peak ﬂow
Measured
peak ﬂow % Predicted Discharge
Dx
64 550 132 24.0% CHF
33 650 420 64.6% CHF
87 402 175 43.5% CHF
66 430 190 44.2% CHF
41 650 370 56.9% CHF
71 552 240 43.5% CHF
71 416 70 16.8% CHF
73 410 325 79.3% CHF
57 605 180 29.8% CHF
59 542 310 57.20% CHF
59 542 310 57.20% CHF
60 591 200 33.84% CHF
65 550 125 22.7% COPD
52 466 225 48.3% COPD
64 572 85 14.86% COPD
55 418 60 14.35% COPD
50 602 240 39.87% COPD
67 554 100 18.05% COPD
other patients with no history of COPD, and these patients
had a mean PEFRF of 40.1%. There was no signiﬁcant
diﬀerence in peak ﬂow between patients with a history of
COPD and those without (P = 0.65).
Of the twelve patients with a known history of CHF, the
PEFR of 48.8%, and 11 received a ﬁnal diagnosis of CHF.
The six patients enrolled who had no history of CHF had
a mean PEFR of 26.3%. Those without a history CHF had
a signiﬁcantly lower PF than those with a history of CHF
(P = 0.05).
One patient had a history of both CHF and COPD. The
PEFR for this patient was 79.3%, and the diagnosis for this
visit was CHF exacerbation.
4. Discussion
Respiratory distress and shortness of breath are frequent
complaints which account for approximately 13% of EMS
transports [1]. Early appropriate treatment can signiﬁcantly
impact the patient’s comfort as well as help prevent further
deterioration and adverse outcomes. Studies have shown
that both emergency physicians and EMS personnel can, in
the majority of cases, make appropriate determination of
the etiology of the patient’s dyspnea on the physical exam
ﬁndings. However, in approximately 30% of patients, the
physical examination alone is not suﬃcient to identify the
cause of the distress [3, 7]. Similar physical ﬁndings such
as dyspnea, tachypnea, wheezing, cough, rales, and jugular
venous distension may be seen in patients with both cardiac
and pulmonary etiologies of dyspnea [3, 8]. Obtaining a
past medical history from the patient and reviewing their
medications may also yield clues. However, many patientsEmergency Medicine International 3
carry multiple diagnoses. Studies have noted the prevalence
of COPD to be as high as 20–32% in patients with known
CHF [2]. This makes the distinction diﬃcult, particularly
in the prehospital environment. Making the appropriate
assessment may be crucial, as incorrect treatment may lead
to adverse outcomes for the patient. Diuretics used to treat
cardiac dyspnea may cause electrolyte disturbances (mainly
potassium and magnesium) and ﬂuid loss [9]. Sympath-
omimetic amines and beta-agonists can cause tachycardia,
increased QTC inducing arrhythmias, and hypokalemia.
In the presence of underlying cardiovascular disease, these
medications may increase the risk of heart failure and
ischemic events including MIs [10].
Utilization of a peak ﬂow test has been proposed as
a simple, low cost, and time-eﬀective instrument to help
diﬀerentiate COPD from CHF as a cause of dyspnea [3,
4, 11]. In this paper the authors examined the mean
percentage of predicted PEFR which was a diﬀerent variable
t h a ni np r e v i o u ss t u d i e s .W h i l en oa b s o l u t ec u t o ﬀ has
been identiﬁed, these data support these previous studies’
ﬁndings demonstrating that PEFR is signiﬁcantly lower in
patients undergoing a COPD exacerbation than that in those
experiencing shortness of breath due to CHF. There was only
one patient enrolled in this study with both COPD and CHF
diagnoses previously documented. The PEFR in this patient
was not signiﬁcantly reduced (79.3%). This was consistent
with the ﬁnal diagnosis of CHF not a COPD exacerbation.
Limitations of this study include a small number of
patients enrolled and the ED setting rather than EMS
environment. The authors ﬁrst sought to determine if the
PEFR would potentially be usefulbefore expanding the study
to the prehospital setting. Study enrollment was limited by
several factors, the ﬁrst of which was the sampling method
utilized as patients were only enrolled when one of the
study investigators was present in the ED. Furthermore,
a number of patients had interventions such as nebulizer
treatments or medications initiated prior to obtaining PEFR.
These limitations preclude the authors from determining
how many patients were lost to enrollment. Although peak
ﬂow meters are easy to use and interpret, a major limitation
to their use is that results are dependent on patients’
understanding and eﬀort [3, 5].
5. Conclusions
The results of this study demonstrate that in this population
there is a diﬀerence between the PEFR values among
patients with COPD as compared with CHF. Although the
sample population is small, these data suggests that COPD
patients show a lower percentage of predicted value for peak
expiratory ﬂow than those with CHF. This study should be
continued in the prehospital setting with a larger sample size
to better assess the utility of using this method among EMS
personnel.
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